Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458. https://doi.org/10.1038/nrc1886
Article CAS PubMed Google Scholar
Manfredi S et al (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259
Article PubMed PubMed Central Google Scholar
Van Gestel YRBM et al (2014) Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol 38:448–454
Lemke J et al (2016) Survival and prognostic factors of colorectal liver metastases after surgical and nonsurgical treatment. Clin Colorectal Cancer 15:e183–e192
Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Javé EE (2017) Hepatic Metastasis from Colorectal Cancer. Euroasian J Hepatogastroenterol 7:166
Article PubMed PubMed Central Google Scholar
Kuipers EJ et al (2015) Colorectal cancer. Nat Rev Dis Primers. https://doi.org/10.1038/nrdp.2015.65
Article PubMed PubMed Central Google Scholar
Oki E et al (2018) Recent advances in treatment for colorectal liver metastasis. Ann Gastroenterol Surg 2:167–175
Article PubMed PubMed Central Google Scholar
Wang J et al (2020) Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med 9:361–373
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767. https://doi.org/10.1016/0092-8674(90)90186-I
Article CAS PubMed Google Scholar
Feng L, Hong S, Gao J and Li J (2019) Whole-exome sequencing characterized the landscape of somatic mutations and pathways in colorectal cancer liver metastasis. J Oncol 2019:2684075
Reiter JG et al (2019) An analysis of genetic heterogeneity in untreated cancers. Nat Rev Cancer 19:639–650
Article CAS PubMed PubMed Central Google Scholar
Molinari C et al (2018) Heterogeneity in colorectal cancer: a challenge for personalized medicine? Int J Mol Sci 2018 19:3733
Ben-Ze’ev A, Basu S and Haase G (2016) Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res 5:699
Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T (2017) Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 8:112103–112115
Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F (2020) Risk of colorectal cancer in inflammatory bowel diseases. Semin Cancer Biol 64:51–60
Guinney J et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350
Article CAS PubMed PubMed Central Google Scholar
Pagès F et al (2018) International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. The Lancet 391:2128–2139
Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 1979(294):1337–1340
Garner H, de Visser KE (2020) Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nat Rev Immunol. https://doi.org/10.1038/s41577-019-0271-z
Article PubMed PubMed Central Google Scholar
Dongre A et al (2017) Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas. Cancer Res 77:3982–3989
Article CAS PubMed PubMed Central Google Scholar
Sanjabi S, Oh SA and Li MO (2017) Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol 9.
Yin K, Xia X, Rui K, Wang T and Wang S (2020) Myeloid-derived suppressor cells: a new and pivotal player in colorectal cancer progression. Front Oncol 10.
Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5:3–8
Article CAS PubMed PubMed Central Google Scholar
Lu T, Gabrilovich DI (2012) Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clin Cancer Res 18:4877–4882
Article CAS PubMed PubMed Central Google Scholar
Parker KH, Beury DW, Ostrand-Rosenberg S (2015) Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment. Adv Cancer Res 128:95–139
Article CAS PubMed PubMed Central Google Scholar
Molon B et al (2011) Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med 208:1949–1962
Article CAS PubMed PubMed Central Google Scholar
Geiger R et al (2016) L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167:829
Article CAS PubMed PubMed Central Google Scholar
Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492–499. https://doi.org/10.1038/ni.2035
Article CAS PubMed Google Scholar
Steinert G et al (2014) Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. Cancer Res 74:1694–1704
Article CAS PubMed Google Scholar
Sahai E et al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20:174–186. https://doi.org/10.1038/s41568-019-0238-1
Article CAS PubMed PubMed Central Google Scholar
Öhlund D et al (2017) Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med 214:579
Article PubMed PubMed Central Google Scholar
Mosa M et al (2020) A Wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer. Cancer Res 80:5569–5582
Article CAS PubMed Google Scholar
Biffi G et al (2019) Il1-induced Jak/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov 9:282–301
Grivennikov SI (2013) Inflammation and colorectal cancer: Colitis-associated neoplasia. Seminars Immunopathol 35:229–244. https://doi.org/10.1007/s00281-012-0352-6
Angevin E et al (2014) A Phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res 20:2192–2204
Article CAS PubMed Google Scholar
Heichler C et al (2019) STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut. https://doi.org/10.1136/gutjnl-2019-319200
Zhong B et al (2022) Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling. Cell Death Dis. https://doi.org/10.1038/s41419-021-04461-6
Article PubMed PubMed Central Google Scholar
Itatani Y, Kawada K, Sakai Y (2019) Transforming growth factor-β signaling pathway in colorectal cancer and its tumor microenvironment. Int J Mol Sci. https://doi.org/10.3390/ijms20235822
Article PubMed PubMed Central Google Scholar
Hawinkels LJAC et al (2014) Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts. Oncogene 33:97–107
Article CAS PubMed Google Scholar
Salovaara R et al (2002) Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut 51:56–59
Article CAS PubMed PubMed Central Google Scholar
Mesker WE et al (2009) Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol 31:169–178
CAS PubMed PubMed Central Google Scholar
Ouahoud S et al (2020) Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer. Oncogene 39:2453–2466
Article CAS PubMed Google Scholar
Voorneveld PW et al (2014) Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of rho and ROCK. Gastroenterology 147:196-208.e13
留言 (0)